Tissue Regenix Group plc's (LON:TRX) Share Price Is Matching Sentiment Around Its Revenues
Jun 01
U.K. (FTSE) Biotech Industry Analysis
UpdatedJun 01, 2024
DataAggregated Company Financials
Companies25
- 7D-0.7%
- 3M8.1%
- 1Y-21.9%
- YTD-9.0%
In the last week, Biotech has been flat. As for the longer term, the industry has declined 22% in the last year. Looking forward, earnings are forecast to grow by 28% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 01 Jun 2024 | UK£3.0b | UK£836.3m | -UK£287,266,028.40 | 30.6x | -10.3x | 3.6x |
| Mon, 29 Apr 2024 | UK£3.1b | UK£895.9m | -UK£215,717,681.40 | 29.7x | -14.4x | 3.5x |
| Wed, 27 Mar 2024 | UK£3.1b | UK£903.1m | -UK£202,183,517.28 | 28.5x | -15.4x | 3.5x |
| Fri, 23 Feb 2024 | UK£3.2b | UK£913.3m | -UK£197,835,821.65 | 31.2x | -16.2x | 3.5x |
| Sun, 21 Jan 2024 | UK£6.4b | UK£1.3b | -UK£245,297,001.00 | 37.3x | -25.9x | 5x |
| Tue, 19 Dec 2023 | UK£6.1b | UK£1.3b | -UK£245,590,728.00 | 37x | -25x | 4.8x |
| Thu, 16 Nov 2023 | UK£6.5b | UK£1.3b | -UK£242,394,041.00 | 39.3x | -26.6x | 5.1x |
| Sat, 14 Oct 2023 | UK£6.6b | UK£1.3b | -UK£251,319,262.00 | 38.4x | -26.1x | 5.1x |
| Mon, 11 Sep 2023 | UK£6.5b | UK£1.3b | -UK£207,007,212.00 | 23.6x | -31.6x | 5.1x |
| Wed, 09 Aug 2023 | UK£6.8b | UK£1.3b | -UK£209,217,365.00 | 23.4x | -32.5x | 5.4x |
| Fri, 07 Jul 2023 | UK£6.7b | UK£1.3b | -UK£209,039,838.00 | 23.9x | -32x | 5.3x |
| Sun, 04 Jun 2023 | UK£7.0b | UK£1.3b | -UK£204,603,564.00 | 22.6x | -34.3x | 5.6x |
| Tue, 02 May 2023 | UK£7.1b | UK£1.3b | -UK£205,973,036.00 | 23.6x | -34.3x | 5.6x |
| Thu, 30 Mar 2023 | UK£7.1b | UK£1.2b | -UK£155,047,316.00 | 24x | -45.7x | 5.7x |
| Sat, 25 Feb 2023 | UK£7.4b | UK£1.2b | -UK£156,973,587.00 | 26.1x | -47.4x | 6x |
| Mon, 23 Jan 2023 | UK£7.7b | UK£1.2b | -UK£139,964,852.00 | 27.7x | -54.7x | 6.6x |
| Wed, 21 Dec 2022 | UK£7.4b | UK£1.2b | -UK£138,103,865.00 | 26.7x | -53.3x | 6.3x |
| Fri, 18 Nov 2022 | UK£7.8b | UK£1.2b | -UK£140,671,510.00 | 25.1x | -55.1x | 6.7x |
| Sun, 16 Oct 2022 | UK£7.0b | UK£1.2b | -UK£150,681,291.00 | 26.2x | -46.7x | 6.1x |
| Tue, 13 Sep 2022 | UK£7.6b | UK£1.1b | -UK£144,420,164.00 | 35.4x | -52.4x | 6.6x |
| Thu, 11 Aug 2022 | UK£7.4b | UK£1.1b | -UK£199,848,602.00 | 37.2x | -36.8x | 6.6x |
| Sat, 09 Jul 2022 | UK£7.1b | UK£1.1b | -UK£175,037,886.00 | 36.3x | -40.4x | 6.3x |
| Mon, 06 Jun 2022 | UK£7.1b | UK£1.1b | -UK£156,906,832.00 | 37.9x | -45.5x | 6.4x |
| Wed, 04 May 2022 | UK£7.2b | UK£1.1b | -UK£139,598,748.00 | 35x | -51.9x | 6.5x |
| Fri, 01 Apr 2022 | UK£7.3b | UK£1.1b | -UK£87,768,925.00 | 41.4x | -83.6x | 6.7x |
| Sun, 27 Feb 2022 | UK£7.7b | UK£1.1b | -UK£130,231,992.00 | 32.8x | -59.4x | 7.1x |
| Tue, 25 Jan 2022 | UK£8.7b | UK£1.1b | -UK£123,582,165.00 | 39.6x | -70.3x | 8x |
| Thu, 23 Dec 2021 | UK£11.2b | UK£1.1b | -UK£121,036,520.00 | 55x | -92.3x | 10.3x |
| Sat, 20 Nov 2021 | UK£11.9b | UK£1.1b | -UK£150,428,894.00 | 66.5x | -79.4x | 11x |
| Mon, 18 Oct 2021 | UK£12.1b | UK£1.1b | -UK£148,206,944.00 | 70.5x | -81.7x | 11x |
| Wed, 15 Sep 2021 | UK£12.2b | UK£1.1b | -UK£143,503,184.62 | 53x | -85.2x | 11.6x |
| Fri, 13 Aug 2021 | UK£12.3b | UK£1.0b | -UK£172,541,949.91 | 29.7x | -71.4x | 12.1x |
| Tue, 08 Jun 2021 | UK£11.4b | UK£1.0b | -UK£166,338,934.52 | 30.7x | -68.3x | 11.2x |
Price to Earnings Ratio
-68.3x
Current Industry PE
- Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 7.2x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 6.3% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -0.56% | |
| Healthcare | -0.64% | |
| Biotech | -0.65% | |
| Biotech | -0.65% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PRTC PureTech Health | UK£2.34 | 2.9% +UK£17.6m | 1.5% | PS242.5x | |
| TRX Tissue Regenix Group | UK£0.69 | 11.3% +UK£4.9m | 35.3% | PS2.1x | |
| OXB Oxford Biomedica | UK£3.31 | 1.2% +UK£4.0m | -28.3% | PS3.7x | |
| GENF Genflow Biosciences | UK£0.03 | 13.0% +UK£1.2m | 29.8% | PB14.7x | |
| PBX ProBiotix Health | UK£0.05 | 17.6% +UK£912.5k | 0% | PS3.9x |